Clinical research organization India
clinical trials india Welcome

Your success. That’s our commitment at Excel Life Sciences. Everything we do is built around leveraging our expertise and passion to ensure that your clinical trials are successful. As the leading Trial Management Organization in India and through our trusted partnerships worldwide, we have the capabilities and bandwidth to take on any project large or small. And with offices and executive leadership based in the United States, you can be sure that we’re available when you are. Excel Life Sciences mixes a customized consultative approach with industry-leading experience and know-how to get results. Specifically our team’s experience includes:

  • 280 years combined experience in Clinical Medicine, Pharmaceutical Medicine and Biometrics
  • 50 years of regulatory experience and top USA and India regulatory executive’s on the ELS advisory board 
  • 350 successfully conducted clinical trials at over 1000 sites 
  • 135 IND approvals & 20+ NDA approvals in US, Europe & Asia
clinical trials india What's New at ELS

Excel Life Sciences Continues Successful Management of Clinical Trials in India as Regulators work to Improve Review Process

Excel Life Sciences President and Chief Medical Officer, Dr. Vijai Kumar, is featured in a just released story on the evolving clinical research landscape in India.  The article which appears in the web-based publication, eCliniqua, discusses some of the ongoing changes underway to create a more robust, efficient and predictable regulatory review process in India for clinical trials. Dr. Kumar shares information on the approach Excel Life Sciences takes to ensure timely regulatory approval for its clients global clinical trials. The company, with a unique operating model involving deployment of its own onsite clinical research coordinators to each site, prides itself on running ethical trials and delivering data quality and data integrity to its clients. Please click here to read the full article

 

BioPharm Executive: Attack Of The Job-Stealing Robots

Achillion Pharmaceuticals, Inc. Hits One Year High After Rumors Gilead Sciences, Inc. Might Buy It Out

Japan Lab Still Unable To Replicate Stem Cell Findings

Fresh From Co-Founding Massively Financed Juno Therapeutics, Banks $400 Million+ To Back New Biotechs

Do The New Ebola Experimental Drugs Actually Work?

2013 Study On Happiness And Gene Expression Flawed, University of North Carolina Study

A Day After Nabbing $55 Million, Parkinson's Biotech Civitas Therapeutics Files For $86 Million IPO

Eating Disorders Boost Autoimmune Disease Risk, University of Helsinki Study

University of California, San Diego (UCSD) Scientist Finds Clearer Obesity, Diabetes Connection

Popular Video Game Can Help MS Patients Reduce Falls, Study

Vaccinogen Plans Move To Baltimore After $80 Million In New Funding

Novo Nordisk A/S Prefers To Grow On Its Own, Not Buy Others: CEO

Novo Nordisk A/S Buys Plant In New Hampshire; Ex-Workers Offered Jobs

FDA Chastises Alexion Pharmaceuticals Inc. For Production Problems Again

Gamblers Are Greedy Bird-Brains, University of Warwick Study

Adhesive Patch Biotech Zosano Pharma, Inc. Postpones $70 Million IPO

Facing Shareholder Demands, Allergan Inc. Reluctantly Sets A Date For Special Meeting

Zai Lab Of Shanghai Raises Over $30 Million In Series A Funding

Houston Biotech Bellicum Pharmaceuticals, Inc. Nabs $55 Million

Teva Pharmaceutical Industries Limited Recalls Parkinson's Disease Medication As It May Be "Super Potent"

REGENX Biosciences, LLC: Attacking A Rare Disease At Its Source With Gene Therapy

With Revenues From Diabetes And Cardiovascular Portfolio At Risk, Analysts Remain Cautious About

"Enrichment" Of Subjects In Clinical Trials Is Critical

Appointment Announcement - President and CEO, Apotex Inc.

Biotech Hiring Surge: Trends To Watch; Industry Tips From Arena Pharmaceuticals, Inc.

Biogen Idec, Inc. (Massachusetts) Poaches Renowned Neurologist From Novartis AG To Lead ALS Innovation Hub

Ex-FDA Head Says Biotech Business Model "Is Basically Falling Apart"

South San Francisco's Calithera Biosciences, Inc. Seeks $80 Million In IPO

Drug Giants Merck & Co., Inc. And Pfizer Inc. Forge Cancer Pact

SoCal's Kite Pharma, Inc. Shares Fly High On Non-Hodgkin's Lymphoma Drug Study Results

Roche Pays $8.3 Billion For Bay Area's InterMune, Inc., Pledges To Keep Employees

Disappointment Looms As Roche Drops Plans To Bid For The Rest Of Chugai Pharmaceutical Co., Ltd. (Japan)

Novozymes A/S' $36 Million, 100-Job Planned R&D Facility Has A Location Complication

Best Biotech Employers In America

Massachusetts' Civitas Therapeutics Locks In $55 Million

Is Amazon.com About To Bust Into Healthcare? FDA Reveals Meeting With The Online Retailer

No Biotech Copycat Drug Lift Off Before 2017: Novartis AG CEO Predicts

VIVUS, Inc. Snags A Group Of Topiramate Patents From Johnson & Johnson

InterMune, Inc. CEO: Bittersweet Ending To A Biotech Comeback Story

5 Illnesses Your Tone Of Voice Can Reveal About Your Health

Redwood City Startup, Aldea Pharmaceuticals, Reels In $24 Million

Move Over San Francisco: Boston Showing Its Pharmaceutical Potential

Tiny Biotech Advaxis, Inc. Inks Another Pact With Merck & Co., Inc. To Test Immune Therapies Against Prostate Cancer

Charles Walker Appointed Imugene Limited CEO

Nordic Nanovector: The Board Appoints As New CEO

StemCutis Attracts Stem Cell Entrepreneur For Top Post

The Reason Why Humans Grow Up So Slowly, Northwestern University Study

Fiber-Based Satiety Ingredient Shown To Make You Eat Less, University of Liverpool Study

Gut Bacteria May Stop Common Food Allergies, University of Chicago Study

Sleep Drunk? Strange Sleep Disorder More Common Than You Think, Stanford University School of Medicine Study

Regado Biosciences, Inc. Permanently Halts Enrollment In Lead Drug Trial

Aspirin Cuts Risk Of Clots, DVT By A Third, University of Sydney Study

Rainmaker: The Serial Dealmaker Who Came To s Rescue

How Tech Could Spell The End Of Animals In Drugs Testing

Liberia: Doctor Given Experimental Ebola Drug Dies

Are You As Old As What You Eat? University College London Researchers Learn How To Rejuvenate Aging Immune Cells

Coffee Drinkers—Your Gums May Thank You, Boston University Study

Phosphagenics Limited's Ex-Chief Guilty Of Theft

Argos Therapeutics, Inc. Commits To New Headquarters In Durham

How Roche And Pfizer Inc. Are On Different M&A Paths

FortuneRock (China) Hauls In $24 Million

Pozen, Inc. Takes Another Step To No Longer Being A Drug Developer; Shrinks Workforce

San Diego Startup, Unveils Drug For Viral Infections Tied To Cervical Cancer

North Carolina's BioKier, Inc. Takes A Shot At A New Kind Of Diabetes Drug

GlaxoSmithKline-Pfizer Inc.'s ViiV Healthcare Wins Approval For HIV Combo Drug

Nail Polish Could Detect Date Rape Drugs, North Carolina State University Study

Cosmetic Eye Procedure May Ease Migraines, Louisiana State University Study

Reading "Fifty Shades" Linked To Unhealthy Behaviors, Michigan State University Study

AxoGen, Inc. Announces Changes To Board Of Directors

Cured? Two Americans Who Had Ebola Will Be Discharged

Pfizer Inc. Eyes Possible Actavis Bid Whilst Weighing Next Steps Over AstraZeneca PLC

Consumer Reports Warns Pregnant Women To Avoid All Tuna

Allergan Inc. Loses Battle To Make Shareholder Vote Moot On Valeant Pharmaceuticals International Bid

FDA Approves Use Of Bristol-Myers Squibb Company, Pfizer Inc.'s Eliquis To Treat Leg, Lung Clots

Unnamed Drug Firm May Invest Up To €1 Billion In Ireland, Hundreds Of New Jobs Expected

Galena Biopharma CEO Allegedly Fired Following Stock-Promotions Scandal, New CEO Named

Look Out Auxilium Pharmaceuticals, BioSpecifics Technologies Corporation Also Touts Positive Data From Phase 2a Study Of CCH For Cellulite

Update: OncoGenex Pharmaceuticals Inc. Phase 3 ENSPIRIT Trial Continuing As Planned

NeuroDerm Ltd. Banks $16 Million

Baxter International, Inc. To Invest $300 Million For Facility Expansion, Will Hire 200 New Workers

Ghent University, To Develop New Site For R&D Companies, 2,000 New Jobs To Be Created

One Mom's Battle To Save Her Child From A Neglected Disease

Sprout Pharmaceuticals Eyes $15 Million From Private Investors To Develop Female Viagra

Auxilium Pharmaceuticals Drug Found Effective Against Cellulite In Phase 2 Study

Baby Skeleton Inside Mother Removed After 38 Years: World???s Longest Ectopic Pregnancy?

Mylan Inc. Makes Second Round Of Bidding For GlaxoSmithKline Drug Portfolio

ViaCyte, Inc. (Formerly Known as Novocell, Inc.) Gains $20 Million Through Deal With Janssen Research & Development

Young Blood To Be Used In Ultimate Rejuvenation Trial, Stanford University Reveals

Autistic Kids Have Extra Synapses In Brain, Study

In Our Digital World, Are Young People Losing The Ability To Read Emotions? University of California, Los Angeles (UCLA) Study

Ebola-Like Virus Beaten By Tekmira Pharmaceuticals Corporation Drug In Study

Popular Antibiotic Linked To Increased Heart Risk, British Medical Journal Reveals

Why Older People Have Trouble Sleeping, Beth Israel Medical Center And University of Toronto Reveal

Pica In Pregnant Teens Linked To Low Iron, Cornell University Study

Brain Training May Help You Multitask Better, University Of Montreal Study

Bigger Weddings, Fewer Partners Linked To Better Marriages, University of Virginia Study

Amicus Therapeutics, Inc. Rockets On Positive Phase 3 Study Data For Rare Disease Drug

More Exits From Ranbaxy Laboratories' Top Management Team

Ebola Fight Hindered By Rumors And Bogus Cures Online

Illumina, Inc. Partners With AstraZeneca PLC, Johnson & Johnson To Create New Genetic Tests For Cancer

FDA Finds Falsified Data, Serious Mold, And Decaying Frogs At Amanta (Formerly Known As Marck Biosciences)

Mannan Pharmaceuticals To Expand R&D With 34 New Hires Over The New Few Years

Eli Lilly and Company's Psoriasis Drug Ixekizumab Succeeds In Late-Stage Studies

GlaxoSmithKline's Asthma Treatment Wins FDA Approval

Dr. Reddy's Laboratories, Inc.'s Breached Packaging Rules: U.S. Regulator

How Illumina, Inc. Is Creating Medicine's Genetic Revolution

NovaBay Pharmaceuticals, Inc. Reports NVC-422 Missed Endpoints In Phase 2 Study

Long-Acting Version Of Baxter International, Inc.'s Hemophilia A Drug BAX 855 Succeeds In Study

Where You Live May Affect How You Fare After Heart Failure, Yale University Study

Severing Nerves May Shrink Stomach Cancers, Study

Love Makes Sex Better For Most Women, Penn State University Study

Tickling Your Ear Could Be Good For Your Heart, University of Leeds Study

Children Face Higher Health Risk From Cell Phones, Reveals

FDA Approves Genzyme Corporation's Gaucher Disease Pill Cerdelga

Good News For Amgen As Parathyroid Drug AMG 416 Succeeds In Phase 3 Study

Allergan Inc. CFO Steps Down In Midst Of Hostile Takeover Bid By Valeant Pharmaceuticals International

Allergan Inc. Approaches Salix Pharmaceuticals, Ltd. To Fend Off Valeant Pharmaceuticals International's Hostile Bid

Amgen, Bristol-Myers Squibb Company On The Prowl For Space In Crowded Cambridge, Massachusetts

Memories Of Errors Foster Faster Learning, Johns Hopkins University Study

Redwood City's Dermira Bags $51 Million, Expands Management Team And Board

Novartis AG, Global Alliance For TB Drug Development Link Up To Search For TB Cure

Coqu?? RadioPharmaceuticals's $250 Million Facility To Bring 164-High-Paying Jobs To Alachua

AstraZeneca PLC, Mitsubishi Tanabe Pharma Corporation Link Up For Diabetes Research

Emergent BioSolutions, MorphoSys AG Strike Prostate Cancer Pact Worth $183 Million

Oncothyreon Inc.'s Lung Cancer Drug EMR 63325-009 Misses Primary Endpoint In Phase 1 Study

222


    Read more..